Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-09-11 15:35:48 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/jco-26-00671
文献链接: https://ascopubs.org/doi/10.1200/JCO-26-00671
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Guang-Liang Chen; Yanjing Guo; Xin Liu; Ya'nan Yang; Youzhou Sang; Xueguan Lu; Si Sun; Xiao Shi; Yan Zhang; Tong-Zhen Chen; Ning Qu; Duo Wen; Xiao-Shuang Niu; Shu Dong; Yu Wang; Yulong Wang; Jiachen Wang; Lu Zhang; Chaosu Hu; Qinghai Ji; Dongmei Ji

